Exploring the influence of particle shape and air velocity on the flowability in the respiratory tract: a computational fluid dynamics approach
- PMID: 31007093
- DOI: 10.1080/03639045.2019.1600534
Exploring the influence of particle shape and air velocity on the flowability in the respiratory tract: a computational fluid dynamics approach
Abstract
Dry powder inhalers (DPIs) are considered a main drug delivery system through pulmonary route. The main objective of this work is to study the flow of differently shaped microparticles in order to find the optimum shape of drug particles that will demonstrate the best flow to the deep lung. The flowability of particles in air or any fluid depends particularly on the drag force which is defined as the resistance of the fluid molecules to the particle flow. One of the most important parameters that affect the drag force is the particles' shape. Computational simulations using COMSOL Multi Physics 5.2 software were performed for investigating the particles flow in the air pathways of lung, and the drag force was calculated for different particles shapes. This was accomplished by screening a set of 17 possible shapes that are expected to be synthesized easily in the micro-scale. In addition, the macro-scale behavior of the investigated shapes was also simulated so as to compare the behavior of the flowing particles in both cases. A very big difference was found between the behavior of particles' flow in the micro and macro scales, but a similar behavior can be obtained if the flow velocity of the microparticles is very high. It was also found that the micro-triangle with aspect ratio 2:1 has the least drag force in both deep and upper lung; so, it should be the shape of choice during the process of particle synthesis for pulmonary drug delivery.
Keywords: COMSOL; Dry powder inhalers; computational fluid dynamics; drag force; flowability; particle shape.
Similar articles
-
Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.Eur J Pharm Sci. 2018 Feb 15;113:171-184. doi: 10.1016/j.ejps.2017.10.022. Epub 2017 Oct 17. Eur J Pharm Sci. 2018. PMID: 29054499
-
Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.Eur J Pharm Sci. 2019 Feb 1;128:299-324. doi: 10.1016/j.ejps.2018.12.008. Epub 2018 Dec 14. Eur J Pharm Sci. 2019. PMID: 30553814 Review.
-
Towards the optimisation and adaptation of dry powder inhalers.Int J Pharm. 2014 Aug 15;470(1-2):120-32. doi: 10.1016/j.ijpharm.2014.04.065. Epub 2014 May 2. Int J Pharm. 2014. PMID: 24792975
-
Estimating inter-patient variability of dispersion in dry powder inhalers using CFD-DEM simulations.Eur J Pharm Sci. 2021 Jan 1;156:105574. doi: 10.1016/j.ejps.2020.105574. Epub 2020 Sep 25. Eur J Pharm Sci. 2021. PMID: 32980431
-
Discrete Modelling of Powder Dispersion in Dry Powder Inhalers - A Brief Review.Curr Pharm Des. 2015;21(27):3966-73. doi: 10.2174/1381612821666150820110958. Curr Pharm Des. 2015. PMID: 26290194 Review.
Cited by
-
Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications.Pharmaceutics. 2021 Feb 1;13(2):189. doi: 10.3390/pharmaceutics13020189. Pharmaceutics. 2021. PMID: 33535512 Free PMC article. Review.
-
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.Daru. 2024 Dec;32(2):761-779. doi: 10.1007/s40199-024-00520-3. Epub 2024 Jun 11. Daru. 2024. PMID: 38861247 Free PMC article. Review.
-
Mice fatal pneumonia model induced by less-virulent Streptococcus pneumoniae via intratracheal aerosolization.Future Microbiol. 2024 Aug 12;19(12):1055-1070. doi: 10.1080/17460913.2024.2355738. Epub 2024 Jun 24. Future Microbiol. 2024. PMID: 38913747 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical